JPRN-C000000370
Completed
未知
Multicenter study for the effect preserving renal function of HMG-CoA reductase inhibitor (simvastatin) in type 2 diabetic nephropathy with hyperlipidemia (MIDN Study) - Multicenter study for the effect preserving renal function of HMG-CoA reductase inhibitor in type 2 diabetic nephropathy (MIDN Study)
Japanese Society of Kidney and Lipids0 sites200 target enrollmentMarch 27, 2006
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Japanese Society of Kidney and Lipids
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Type 1 diabetes mellitus. 2\) The subject has cardio\-vascular complications as follows: receiving coronary artery bypass grafting (CABG) or percutaneous transluminal coronary angioplasty (PTCA) within 3 months; unstable angina; myocardial infarction; transient ischemic attack (TIA) within 6 months, congestive heart failure classified into class III or IV of New York Heart Association (NYHA); cerebral infarction within 3months. 3\) The subject has non diabetic nephropathy such as chronic glomerulonephritis, nephrotic syndrome and polycystic kidney. 4\) The subject's serum creatinine is more than 2\.5mg/dL. 5\) The subject has secondary hypertension except that due to diabetes. 6\) The subject's HbA1c is more than 9%. 7\) The subject is inappropriate for participation in the study for other reasons, as determined by an investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A multicenter study to examine renal protection by a combination of an HMG-CoA reductase inhibitor and losartan in patients with dyslipidemia associated with IgA nephropathyJPRN-UMIN000002887Fukuoka University Faculty of Medicine80
Recruiting
Not Applicable
A clinical study to evaluate the effect of renal impairment of the pharmacokinetics of oral administration of Factive Tab. 320mgDiseases of the genitourinary systemKCT0006146Chonnam National University Hospital28
Not yet recruiting
Not Applicable
Study of renal function renal protective effect of cooling method in laparoscopic partial nephrectomyRenal cell cacinomaJPRN-UMIN000013867Kansai Medical University30
Completed
Not Applicable
An observational study of renal protection by intravenous amino acid therapy in abdominal aortic aneurysm surgeryabdominal aortic aneurysmJPRN-UMIN000038527ational Cerebral and Cardiovascular Center2,000
Completed
Not Applicable
Examination of the effect of renal protection of aliskiren in chronic renal failure patient with hypertension (preservation period)Chronic renal failure patient with hypertension under going rennin-angiotensin treatment (ARB/ACE-inhibitor) (preservation period)JPRN-UMIN000002478Kure Kyousai Hospital200